Vertex Pharmaceuticals Incorporated (VRTX) Presents at BofA Securities 2023 Health Care Conference (Transcript)Seeking Alpha • 05/13/23
This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?The Motley Fool • 05/11/23
This Incredible Growth Stock Has All the Hallmarks of a Prototypical Warren Buffett StockThe Motley Fool • 05/06/23
Vertex Announces U.S. FDA Approval for KALYDECO® (ivacaftor) to Treat Eligible Infants With CF Ages 1 Month and OlderBusiness Wire • 05/03/23
Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Surpass EstimatesZacks Investment Research • 05/01/23
Vertex Pharmaceuticals Keeps Its Outlook Despite Beating Views, And DivesInvestors Business Daily • 05/01/23
Strength Seen in Vertex (VRTX): Can Its 5.0% Jump Turn into More Strength?Zacks Investment Research • 04/28/23